Walleye Trading LLC Puma Biotechnology, Inc. Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $217,147 - $330,308	-101,947 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.85 - $6.58 $290,548 - $670,811	101,947 New	101,947 $310,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $291,461 - $676,208	-46,411 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $263,464 - $434,919	40,533 Added 689.57%	46,411 $406,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $41,816 - $61,410	4,779 Added 434.85%	5,878 $63,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $100,089 - $232,892	-4,987 Reduced 81.94%	1,099 $22,000
Q3 2018 Nov 14, 2018	BUY	$41.2 - $59.85 $250,743 - $364,247	6,086 New	6,086 $279,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $154M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.